Generated Narrative
Resource "cfsb1639991356428" (Language "en")
status: final
type: Package Leaflet (#100000155538)
date: 2015-02-07T13:28:17Z
author: See above (Organization/cfsb1639754108144)
title: TEST PURPOSES ONLY - Monuril Vulcan ePI
confidentiality: unrestricted
Do not take Monuril if you:
Conditions you need to look out for
Monuril can cause serious side effects. These include allergic reactions and an inflammation of the large intestine. You must look out for certain symptoms while you are taking this medicine, to reduce the risk of any problems. See “Serious side effects” in Section 4.Children and adolescents
Do not give this medicine to children less than 12 years of age, as its safety and efficacy have not been established in this age group.Other medicines and Monuril
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription. This is especially important if you are taking:Monuril with food
Food may delay the absorption of fosfomycin. Therefore, this medicinal product should be taken on an empty stomach (2-3 hours before or 2-3 hours after a meal).Pregnancy, breast-feeding and fertility
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.If you are pregnant your doctor will only give you this medicine when it is clearly needed.
Breast-feeding mothers can take a single oral dose of this medicine.
Driving and using machines
You may experience side effects, such as dizziness, which may affect your ability to drive or use machines.Monuril contains
Sodium This medicine contains less than 1 mmol sodium (23 mg) per sachet that is to say essentially 'sodium-free'. Sucrose If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product. Sulphites May rarely cause severe hypersensitivity reactions and bronchospasm.
3. How to take Monuril
Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.In case of treatment of uncomplicated infection of the bladder, in women and female adolescents the recommended dose is 1 sachet of Monuril (3 g Fosfomycin).
When used as antibiotic prophylaxis for transrectal prostate biopsy the recommended dose is 1 sachet of Monuril (3 g fosfomycin) 3 hours prior to the procedure and 1 sachet of Monuril (3 g fosfomycin) 24 hours after the procedure.
Use in patients with renal impairment
This medicine should not be used in patients with severe renal impairment (creatinin clearance < 10 ml/min).Use in children and adolescents
This medicine should not be used in children less than 12 years of age.Method of administration
For oral use.Take this medicine by mouth, on an empty stomach (2-3 hours before or 2-3 hours after a meal), preferably before going to bed after emptying the bladder.
Dissolve the content of one sachet in a glass of water and drink immediately.
If you take more Monuril than you should
If you accidentally take more than your prescribed dose, contact your doctor or pharmacist.If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.Serious side effects
While taking Monuril, if you develop any of the following symptoms you should stop taking the medicine and contact your doctor immediately:
Other side effects
Common (may affect up to 1 in 10 people):Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system website: www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and the blister after “EXP”. The expiry date refers to the last day of that month.
This medicine does not require any special storage conditions.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
6. Contents of the pack and other information
What Monuril contains
What Monuril looks like and contents of the pack
White granules for oral solution in a single dose sachet.Sachets are four layers laminate of: paper/polyethylene/aluminium/polyethylene.
Monuril is available in packs containing:
1 sachet of 8 g of granules (3 g fosfomycin) 2 sachets of 8 g of granules (3 g fosfomycin) 5 sachets of 8 g of granules (3 g fosfomycin). Not all pack sizes may be marketed.Marketing Authorisation Holder and Manufacturer
Marketing Authorisation Holder: Zambon S.p.A. Via Lillo del Duca, 10 20091 Bresso (Milan) - Italy Tel: +39 02 665 241 Fax: +39 02 665 01 492Manufacturer:
Zambon S.p.A. Via della Chimica, 9 36100 Vicenza - ItalyDistributor
Profile Pharma Limited Bicentennial Building Southern Gate West Sussex PO19 8EZ UK Tel: +44 (0) 800 0288 942 Email: info.profilepharma@zambongroup.comThis leaflet was last revised in November 2020.
Generated Narrative
Resource "cfsb1639753766266"
identifier: id: ORG-100000380 (OFFICIAL)
active: true
type: Manufacturer (#220000000033)
name: Zambon S.p.A.
address: Via della Chimica, 9 36100 Vicenza – Italy(WORK)
Generated Narrative
Resource "cfsb1639754108144"
identifier: id: ORG-100000380 (OFFICIAL)
active: true
type: Marketing authorisation holder (#220000000034)
name: Zambon S.p.A.
telecom: +39 02 665 241
address: Via Lillo del Duca, 10 20091 Bresso (Milan) – Italy(WORK)
Generated Narrative
Resource "cfsb1639015880655"
identifier: id: ORG-100013412 (OFFICIAL)
active: true
type: Medicines Regulatory Authority (#/#220000000033)
name: European Medicines Agency
address: Domenico Scarlattilaan 6 1083 HS Amsterdam The Netherlands(WORK)
Generated Narrative
Resource "cfsb1639761980721"
identifier: id: PL 31654/0006 (OFFICIAL)
subject: See above (MedicinalProductDefinition/cfsb1639760186202)
type: Marketing Authorisation (#/#100000072062)
region: European Union (unknown#eu)
status: Active (PublicationStatus#active)
statusDate: 2015-02-07T13:28:17Z
holder: See above (Organization/cfsb1639754108144)
regulator: See above (Organization/cfsb1639015880655)
Generated Narrative
Resource "cfsb1639760186202"
identifier: id: PL 31654/0006 (OFFICIAL)
type: Marketing Authorisation (#/#100000072062)
domain: Human use (#/#100000000012)
status: Active (PublicationStatus#active)
legalStatusOfSupply: Medicinal product subject to medical prescription (#/#100000072084)
name
productName: MONURIL 3 g granules for oral solution
type: Full name (#/#220000000001)
NameParts
- Part Type * granules for oral solution Pharmaceutical dose form part (#/#220000000005) CountryLanguages
- Country Jurisdiction Language * gb (unknown#gb) European Union (unknown#eu) English (Tags for the Identification of Languages#en)
Generated Narrative
Resource "cfsb1639758328687"
identifier: id: PL 31654/0006-5 (OFFICIAL)
name: 5 sachets of 8 g of granules (3 g fosfomycin).
type: Chemical Medicinal Product (#100000155527)
packageFor: See above (MedicinalProductDefinition/cfsb1639760186202)
status: Active (PublicationStatus#active)
statusDate: 2008-09-19
containedItemQuantity: 5 Sachet (Details: [not stated] code 200000002143 = '200000002143')
manufacturer: See above (Organization/cfsb1639753766266)
package
type: Sachet (#200000002143)
material: Paper (#200000003207), PolyEthylene (#200000003214), Aluminium (#200000003200)
manufacturer: See above (Organization/cfsb1639753766266)
containedItem
Generated Narrative
Resource "cfsb1639764389611"
identifier: id: PL 31654/0006-2 (OFFICIAL)
name: 2 sachets of 8 g of granules (3 g fosfomycin).
type: Chemical Medicinal Product (#100000155527)
packageFor: See above (MedicinalProductDefinition/cfsb1639760186202)
status: Active (PublicationStatus#active)
containedItemQuantity: 2 Sachet (Details: [not stated] code 200000002143 = '200000002143')
manufacturer: See above (Organization/cfsb1639753766266)
package
type: Sachet (#200000002143)
material: Paper (#200000003207), PolyEthylene (#200000003214), Aluminium (#200000003200)
manufacturer: See above (Organization/cfsb1639753766266)
containedItem
Generated Narrative
Resource "cfsb1639764389612"
identifier: id: PL 31654/0006-1 (OFFICIAL)
name: 1 sachet of 8 g of granules (3 g fosfomycin).
type: Chemical Medicinal Product (#100000155527)
packageFor: See above (MedicinalProductDefinition/cfsb1639760186202)
status: Active (PublicationStatus#active)
containedItemQuantity: 1 Sachet (Details: [not stated] code 200000002143 = '200000002143')
manufacturer: See above (Organization/cfsb1639753766266)
package
type: Sachet (#200000002143)
material: Paper (#200000003207), PolyEthylene (#200000003214), Aluminium (#200000003200)
manufacturer: See above (Organization/cfsb1639753766266)
containedItem
Generated Narrative
Resource "cfsb1639760977050"
identifier: id: 0xE857DA811B4A6F3BD57810C45D2EA1ED (OFFICIAL)
status: active
formOf: See above (MedicinalProductDefinition/cfsb1639760186202)
administrableDoseForm: Granules and solvent for oral suspension (#/#100000116155)
producedFrom: See above (ManufacturedItemDefinition/cfsb1639756818482)
routeOfAdministration
code: oral use (#100000073619)
TargetSpecies
- Code * Human (#/#100000109093)
Generated Narrative
Resource "cfsb1639756818482"
identifier: id: PL 31654/0006 (OFFICIAL)
status: active
manufacturedDoseForm: Granules for oral solution (#100000073365)
unitOfPresentation: Sachet (#200000002143)
manufacturer: See above (Organization/cfsb1639753766266)
Generated Narrative
Resource "cfsb1639762372322"
status: active
role: Excipient (#100000072082)
- | Manufacturer |
* | See above (Organization/cfsb1639753766266) |
substance
Generated Narrative
Resource "cfsb1639754408039"
status: active
role: active (#/#00000072072)
- | Manufacturer |
* | See above (Organization/cfsb1639753766266) |
substance
strength
presentation: 5.631 g
basis: active ingredient - moiety is basis of strength (RoleClass#ACTIM)
referenceStrength
strength: 3 g
Generated Narrative
Resource "cfsb1639762593730"
status: active
role: Excipient (#100000072082)
- | Manufacturer |
* | See above (Organization/cfsb1639753766266) |
substance
Generated Narrative
Resource "cfsb1639762372321"
status: active
role: Excipient (#100000072082)
- | Manufacturer |
* | See above (Organization/cfsb1639753766266) |
substance
Generated Narrative
Resource "cfsb1639762372323"
status: active
role: Excipient (#100000072082)
- | Manufacturer |
* | See above (Organization/cfsb1639753766266) |
substance